BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 34156040)

  • 1. Inorganic nanomaterials with rapid clearance for biomedical applications.
    Wang X; Zhong X; Li J; Liu Z; Cheng L
    Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior.
    Zhou H; Ge J; Miao Q; Zhu R; Wen L; Zeng J; Gao M
    Bioconjug Chem; 2020 Feb; 31(2):315-331. PubMed ID: 31765561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive inorganic nanomaterials for cancer theranostics.
    Pei Z; Lei H; Cheng L
    Chem Soc Rev; 2023 Mar; 52(6):2031-2081. PubMed ID: 36633202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.
    Rahimkhoei V; Alzaidy AH; Abed MJ; Rashki S; Salavati-Niasari M
    Adv Colloid Interface Sci; 2024 Jul; 329():103204. PubMed ID: 38797070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putting Hybrid Nanomaterials to Work for Biomedical Applications.
    Zhang D; Chen Y; Hao M; Xia Y
    Angew Chem Int Ed Engl; 2024 Apr; 63(16):e202319567. PubMed ID: 38429227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration and translocation of functional inorganic nanomaterials into biological barriers.
    Cong Y; Baimanov D; Zhou Y; Chen C; Wang L
    Adv Drug Deliv Rev; 2022 Dec; 191():114615. PubMed ID: 36356929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
    Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
    J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Two-Dimensional Nanomaterials for Cancer Therapy.
    Guo Z; Ouyang J; Kim NY; Shi J; Ji X
    Chemphyschem; 2019 Oct; 20(19):2417-2433. PubMed ID: 31342629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications.
    Yang G; Phua SZF; Bindra AK; Zhao Y
    Adv Mater; 2019 Mar; 31(10):e1805730. PubMed ID: 30614561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold-based Inorganic Nanohybrids for Nanomedicine Applications.
    Ding X; Li D; Jiang J
    Theranostics; 2020; 10(18):8061-8079. PubMed ID: 32724458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy.
    Medina-Reyes EI; Garcia-Viacobo D; Carrero-Martinez FA; Chirino YI
    Crit Rev Ther Drug Carrier Syst; 2017; 34(1):35-61. PubMed ID: 28322140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo clearable inorganic nanophotonic materials: designs, materials and applications.
    Nie J; Li Y; Han G; Qiu J
    Nanoscale; 2019 Jul; 11(27):12742-12754. PubMed ID: 31265038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
    ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.